SGOT Reagent Set
510(k) K844322
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK844322 | Date27 Nov 1984 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- CIQ
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1100
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The SGOT Reagent Set is a diagnostic reagent intended for use in clinical chemistry assays. It is designed to measure serum glutamic oxaloacetic transaminase (SGOT), an enzyme primarily found in the liver, heart, skeletal muscle, and kidneys. This measurement aids in the diagnosis and monitoring of liver disease, heart conditions, and muscle disorders. The reagent set falls under the classification of Diazo reagents for transaminase assays, as defined by regulatory nomenclature.
This reagent set is supplied as a liquid formulation and is intended for single-use in clinical laboratory settings. It is classified as a Class II medical device under FDA regulations (862.1100) and has received FDA 510(k) clearance (K844322) as substantially equivalent to a predicate device. The product is distributed in a format suitable for routine laboratory use, with sterility and stability ensured for its intended application. No additional regulatory approvals beyond the 510(k) clearance are stated in the provided data.
Other devices from Livonia Diagnostics, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the SGOT Reagent Set used for in clinical settings?
The SGOT Reagent Set is designed for clinical chemistry assays to measure serum glutamic oxaloacetic transaminase (SGOT), an enzyme found in the liver, heart, skeletal muscle, and kidneys. Elevated SGOT levels can indicate liver disease, heart conditions, or muscle disorders, making this reagent essential for diagnosing and monitoring these conditions in laboratory settings.
How is the SGOT Reagent Set supplied and intended for use?
The SGOT Reagent Set is supplied as a liquid formulation, specifically formulated for single-use in clinical laboratories. It is intended to be used once per assay, ensuring accuracy and consistency in SGOT measurements without carryover risks from reuse.
Is the SGOT Reagent Set sterile and stable for its intended use?
Yes, the SGOT Reagent Set is classified as sterile and stable for its intended application in clinical laboratory settings. This ensures reliability and safety when performing SGOT assays, as the manufacturer has validated its formulation to maintain integrity until use.
What regulatory clearance does the SGOT Reagent Set hold?
The SGOT Reagent Set has received FDA 510(k) clearance (K844322) as substantially equivalent to a predicate device. This clearance confirms its compliance with FDA regulations for Class II medical devices under the product code CIQ, ensuring it meets established safety and performance standards for clinical chemistry assays.
Can this reagent set be used for other transaminase assays besides SGOT?
The SGOT Reagent Set is specifically designed for measuring SGOT (serum glutamic oxaloacetic transaminase) and falls under the category of Diazo reagents for transaminase assays. While it may share some chemical principles with other transaminase assays, it is not intended for use with AST (aspartate transaminase) or other enzymes without explicit manufacturer validation or additional reagents.